LIPNX
Price
$9.64
Change
+$0.03 (+0.31%)
Updated
Apr 23 closing price
Net Assets
104.16M
VIPIX
Price
$9.42
Change
+$0.03 (+0.32%)
Updated
Apr 23 closing price
Net Assets
27.24B
Ad is loading...

LIPNX vs VIPIX

Header iconLIPNX vs VIPIX Comparison
Open Charts LIPNX vs VIPIXBanner chart's image
Loomis Sayles Inflation Protected Secs N
Price$9.64
Change+$0.03 (+0.31%)
VolumeN/A
Net Assets104.16M
Vanguard Inflation-Protected Secs I
Price$9.42
Change+$0.03 (+0.32%)
VolumeN/A
Net Assets27.24B
LIPNX vs VIPIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIPNX vs. VIPIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIPNX is a Hold and VIPIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIPIX has more cash in the bank: 27.2B vs. LIPNX (104M). VIPIX (4.16) and LIPNX (4.04) have matching dividends . LIPNX was incepted earlier than VIPIX: LIPNX (8 years) vs VIPIX (21 years). LIPNX (0.56) is less costly to investors than VIPIX (0.07). LIPNX is a more actively managed with annual turnover of: 40.00 vs. VIPIX (34.00). LIPNX has a lower initial minimum investment than VIPIX: LIPNX (1000000) vs VIPIX (5000000). VIPIX (6.12) and LIPNX (5.83) have marching annual gain over last year. VIPIX return over 5 years is better than : 6.87 vs. LIPNX (5.36).
LIPNXVIPIXLIPNX / VIPIX
Total Expense Ratio0.350.07500%
Annual Report Gross Expense Ratio0.560.07800%
Fund Existence8 years21 years-
Gain YTD2.4582.67792%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets104M27.2B0%
Annual Yield % from dividends4.044.1697%
Returns for 1 year5.836.1295%
Returns for 3 years0.020.376%
Returns for 5 years5.366.8778%
Returns for 10 yearsN/A22.14-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIEUX38.98N/A
N/A
Fidelity Europe
JMGZX37.88N/A
N/A
JPMorgan Mid Cap Growth R2
FIKWX11.64N/A
N/A
Fidelity Advisor Asset Manager 30% Z
LYFIX12.09N/A
N/A
AlphaCentric Life Sciences & Hlthcare I
MAIRX8.54N/A
N/A
Victory Trivalent Intl Fd-Core Eq R6